r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SL

Sung Lee

Insider · EVP, Chief Financial Officer · CYTK

Sung Lee files insider transactions with the SEC as an evp, chief financial officer of Cytokinetics (CYTK). We hold 5 disclosed purchases and sales filed since 26 November 2019, 3 of them in the last 90 days.

  • Files forCYTK
  • Disclosed buys and sells5 in all, 3 in the last 90 days
  • Last disclosure2 July 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 31 May 2024 — 1 July 2026EVP, Chief Financial Officer · Cytokinetics (CYTK)51 Form 4 lines · source: SEC Form 4
  • Filed 2 January 2026 — 5 June 2026Director · Tango Therapeutics (TNGX)8 Form 4 lines · source: SEC Form 4
  • Filed 27 March 2023 — 27 March 2024EVP & Chief Financial Officer · Vir Biotechnology (VIR)5 Form 4 lines · source: SEC Form 4
  • Filed 25 November 2019 — 25 November 2020EVP, Chief Financial Officer · Sangamo Therapeutics (SGMO)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

69 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.